Bipolar Disorder – Market outlook, Epidemiology, Competitive Landscape and Market Forecast Report – 2020 To 2030

Bipolar Disorder, also known as manic-depressive illness, is a brain disorder that causes a person's mood, energy, and ability to function to change dramatically. It is different from the regular ups and downs people experience: the symptoms of BD are more severe. It is characterized by recurrent episodes of mania and, more frequently, depression. The condition has a high recurrence rate, and if untreated, it has an approximately 15% risk of death by suicide. It is the third leading cause of death among people aged 15 to 24 years and is the sixth leading cause of disability (lost years of healthy life) for people aged 15 to 44 years in the developed world. It usually manifests itself during late adolescence or early adulthood. However, some people experience their first symptoms as children, while others experience them later in life. It is frequently misdiagnosed as a disease, and people may suffer for years before receiving proper diagnosis and treatment. Like diabetes or heart disease, Bipolar Disorder is a chronic illness that must be carefully managed throughout life.

The prevalence of Bipolar Disorder in the USA varies from 0.8% to 4.4% of cases among the 18 and above population

The competitive landscape of Bipolar Disorder includes country-specific approved and pipeline therapies. Any asset/product-specific designation or review and Accelerated Approval are tracked and supplemented with analyst commentary.

KOLs insights of Bipolar Disorder across 8 MM market from the center of Excellence/ Public/ Private hospitals participated in the study. Insights around current treatment landscape, epidemiology, clinical characteristics, future treatment paradigm, and Unmet needs.

Bipolar Disorder Market Forecast: Patient Based Forecast Model (MS. Excel Based Automated Dashboard) which Data Inputs with sourcing, Market Event, and Product Event, Country specific Forecast Model, Market uptake and patient share uptake, Attribute Analysis, Analog Analysis, Disease burden, and pricing scenario, Summary, and Insights.

Read more: Bipolar Disorder – Market outlook, Epidemiology, Market Forecast, and Competitive Landscape Report – 2020 To 2030

S. No    Asset               Company                                 Stage

1          Seroquel IR       Otsuka Pharmaceutical Phase 1

2          Asenapine and Olanzapine        Organon and Co            Phase 3

3          FK949E            Astellas Pharma Inc      Phase 3

4          BXCL501          BioXcel Therapeutics Inc           Phase 1

5          Cariprazine       Forest Laboratories       Phase 3

6          AQW051           Novartis Pharmaceuticals          Phase 2

7          GSK1014802    Biogen  Phase 1

8          Divalproex Sodium        Sandoz Phase 1

9          loxapine            Lee's Pharmaceutical Limited     Phase 3

10        Lurasidone        Sunovion          Phase 3

Continued
 

Comments

Post a Comment

Popular posts from this blog

Acne Vulgaris – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2022 To 2032

Image
  Acne vulgaris, a prevalent pilosebaceous unit inflammatory skin disorder, follows a persistent course. Typically presenting as papules, pustules, or nodules, it primarily occurs on the face but can also impact the upper arms, trunk, and back. The development of acne results from the sebaceous glands' heightened sensitivity to normal androgen levels, aggravated by Cutibacterium acnes (formerly known as Propionibacterium acnes), a bacterial species that triggers inflammation. The pathogenesis of acne vulgaris involves a complex interplay of factors such as the activation of sebaceous glands by androgens, imbalances in the pilosebaceous follicle microbiome, and cellular immune responses. Genetic predisposition and dietary influences also contribute to the condition's onset and progression. The initial stage is the micro-comedo, a small plug primarily composed of corneocytes in the lower follicular infundibulum. Microcomedones evolve into various acne lesions, including closed co...
Read more

Metabolic Syndrome – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Image
  Metabolic syndrome refers to a clustering of multiple disorders that collectively increase an individual's susceptibility to atherosclerotic cardiovascular disease, insulin resistance, diabetes mellitus, as well as vascular and neurological complications such as cerebrovascular accidents. The underlying causes of metabolic syndrome typically include excess weight, obesity, a sedentary lifestyle, and genetic predisposition. This syndrome exerts detrimental effects on various body systems. Insulin resistance, a key component of metabolic syndrome, leads to microvascular damage, increasing the risk of endothelial dysfunction, vascular resistance, hypertension, and inflammation of vessel walls. Bariatric surgery is recognized as the most effective standalone therapy for metabolic syndrome. However, patients undergoing this procedure require long-term follow-up to mitigate potential surgical, nutritional, and psychiatric complications. Thelansis’s “Metabolic Syndrome Market Outl...
Read more

Type 1 Diabetes Mellitus (T1D) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Image
  Type 1 Diabetes Mellitus (T1D) is characterized as an autoimmune disorder resulting in the autoimmune destruction of insulin-producing pancreatic beta cells. This condition necessitates life-long insulin replacement, administered through multiple daily insulin injections, insulin pump therapy, or an automated insulin delivery system. The absence of insulin can lead to the development of Diabetic Ketoacidosis (DKA), a life-threatening condition. The most common symptoms associated with this disease are polyuria and polydipsia. Effective management of T1D involves: Multiple daily insulin injections Insulin pump therapy An automated insulin delivery system in conjunction with glucose monitoring Continuous Glucose Monitoring (CGM) is the preferred method. However, all individuals with T1D should be capable of performing Blood Glucose Monitoring (BGM) via capillary blood if CGM is not available. Acute complications of diabetes primarily include hypo...
Read more